These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 9254703)
41. [Clone, expression and cleavage activity of anti-caspase-7 hammerhead ribozyme in vitro]. Zhang W; Xie Q; Zhou XQ; Jiang S; Jin YX Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):684-7. PubMed ID: 15623380 [TBL] [Abstract][Full Text] [Related]
42. Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA. Hovig E; Maelandsmo G; Mellingsaeter T; Fodstad O; Mielewczyk SS; Wolfe J; Goodchild J Antisense Nucleic Acid Drug Dev; 2001 Apr; 11(2):67-75. PubMed ID: 11334142 [TBL] [Abstract][Full Text] [Related]
43. Induction of ribozyme activity by anti-ribozyme oligonucleotides. Komatsu Y; Yamashita S; Kazama N; Ohtsuka E Nucleic Acids Symp Ser; 1999; (42):279-80. PubMed ID: 10780488 [TBL] [Abstract][Full Text] [Related]
44. [Design and preparation of the multimeric self-cleavable hammerhead ribozyme targeting apple scar skid viroid and its activity detection in vitro]. Sun JL; Zhang CC; Zhou L; Yang XC Sheng Wu Gong Cheng Xue Bao; 2002 Sep; 18(5):588-92. PubMed ID: 12561204 [TBL] [Abstract][Full Text] [Related]
45. Hammerhead ribozyme-mediated silencing of the mutant fibrillin-1 of tight skin mouse: insight into the functional role of mutant fibrillin-1. Menon RP; Menon MR; Shi-Wen X; Renzoni E; Bou-Gharios G; Black CM; Abraham DJ Exp Cell Res; 2006 May; 312(9):1463-74. PubMed ID: 16488411 [TBL] [Abstract][Full Text] [Related]
46. A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability. Hendry P; McCall MJ; Santiago FS; Jennings PA Nucleic Acids Res; 1992 Nov; 20(21):5737-41. PubMed ID: 1280808 [TBL] [Abstract][Full Text] [Related]
47. Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition. Zhou C; Bahner I; Rossi JJ; Kohn DB Antisense Nucleic Acid Drug Dev; 1996; 6(1):17-24. PubMed ID: 8783792 [TBL] [Abstract][Full Text] [Related]
48. Inosine(15.1) hammerhead ribozymes for targeting the transthyretin-30 mutation. Pröpsting MJ; Blaschke M; Haas RE; Genschel J; Hedrich HJ; Manns MP; Schmidt HH Biochem Biophys Res Commun; 1999 Jul; 260(2):313-7. PubMed ID: 10403767 [TBL] [Abstract][Full Text] [Related]
49. Cis-cleavage affects hammerhead and hairpin ribozyme steady-state levels differently and has strong impact on trans-targeting efficiency. Andäng M; Maijgren-Steffensson C; Hinkula J; Ahrlund-Richter L Oligonucleotides; 2004; 14(1):11-21. PubMed ID: 15104892 [TBL] [Abstract][Full Text] [Related]
50. A helix 1-extended hairpin ribozyme exhibits altered cleavage behavior in vitro. Moosbauer J; Tabler M Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):79-87. PubMed ID: 9149843 [TBL] [Abstract][Full Text] [Related]
51. A ribozyme that enhances gene suppression in tobacco protoplasts. Perriman R; Graf L; Gerlach WL Antisense Res Dev; 1993; 3(3):253-63. PubMed ID: 8286926 [TBL] [Abstract][Full Text] [Related]
52. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction. Murray JB; Dunham CM; Scott WG J Mol Biol; 2002 Jan; 315(2):121-30. PubMed ID: 11779233 [TBL] [Abstract][Full Text] [Related]
53. A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing. Fukuda M; Kurihara K; Tanaka Y; Deshimaru M RNA; 2012 Sep; 18(9):1735-44. PubMed ID: 22798264 [TBL] [Abstract][Full Text] [Related]
54. Hairpin ribozyme-mediated cleavage of the full-length beta-glucuronidase (GUS) mRNA. Hisamatsu S; Sonoki S; Kikuchi Y Biosci Biotechnol Biochem; 1995 Feb; 59(2):294-7. PubMed ID: 7766027 [TBL] [Abstract][Full Text] [Related]
55. Measurements of weak interactions between truncated substrates and a hammerhead ribozyme by competitive kinetic analyses: implications for the design of new and efficient ribozymes with high sequence specificity. Kasai Y; Shizuku H; Takagi Y; Warashina M; Taira K Nucleic Acids Res; 2002 Jun; 30(11):2383-9. PubMed ID: 12034825 [TBL] [Abstract][Full Text] [Related]
57. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries. Takagi Y; Suyama E; Kawasaki H; Miyagishi M; Taira K Biochem Soc Trans; 2002 Nov; 30(Pt 6):1145-9. PubMed ID: 12440992 [TBL] [Abstract][Full Text] [Related]
58. Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes. Sakamoto N; Wu CH; Wu GY J Clin Invest; 1996 Dec; 98(12):2720-8. PubMed ID: 8981917 [TBL] [Abstract][Full Text] [Related]
59. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. Bertrand EL; Rossi JJ EMBO J; 1994 Jun; 13(12):2904-12. PubMed ID: 8026475 [TBL] [Abstract][Full Text] [Related]
60. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev. Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]